Cyberonics Kicking Off Obesity Phase I, Depression Phase III Trials
This article was originally published in The Gray Sheet
Executive Summary
Cyberonics will decide whether to proceed with U.S. pivotal trials of its NeuroCybernetic Prosthesis (NCP) vagus nerve stimulation system (VNS) for treatment of morbid obesity sometime in summer 2002.